US HB965 | 2019-2020 | 116th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 55-14)
Status: Introduced on February 5 2019 - 25% progression, died in chamber
Action: 2019-05-16 - Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 5 2019 - 25% progression, died in chamber
Action: 2019-05-16 - Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III.
Text: Latest bill text (Introduced) [PDF]
Summary
To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
Title
CREATES Act of 2019 Creating and Restoring Equal Access to Equivalent Samples Act of 2019
Sponsors
History
Date | Chamber | Action |
---|---|---|
2019-05-16 | House | Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III. |
2019-05-16 | House | PERMISSION TO FILE SUPPLEMENTAL - Ms. Lofgren asked unanimous consent that Committee on the Judiciary be authorized to file a supplemental report on the bill, H.R. 965. Agreed to without objection. |
2019-05-10 | House | Placed on the Union Calendar, Calendar No. 33. |
2019-05-10 | House | Reported by the Committee on Judiciary. H. Rept. 116-55, Part II. |
2019-05-10 | House | Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-55, Part I. |
2019-04-30 | House | Ordered to be Reported by Voice Vote. |
2019-04-30 | House | Committee Consideration and Mark-up Session Held. |
2019-04-03 | House | Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0. |
2019-04-03 | House | Committee Consideration and Mark-up Session Held. |
2019-03-27 | House | Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . |
2019-03-27 | House | Subcommittee Consideration and Mark-up Session Held. |
2019-03-22 | House | Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. |
2019-02-06 | House | Referred to the Subcommittee on Health. |
2019-02-05 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-02-05 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-02-05 | House | Introduced in House |
Same As/Similar To
SB340 (Same As) 2019-02-06 - Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.
HB987 (Related) 2019-05-20 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
HB2700 (Related) 2019-06-26 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB1895 (Related) 2019-07-08 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 133.
HB1865 (Related) 2019-12-20 - Became Public Law No: 116-94. (TXT | PDF)
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
HB3947 (Related) 2019-08-28 - Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties.
HB987 (Related) 2019-05-20 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
HB2700 (Related) 2019-06-26 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB1895 (Related) 2019-07-08 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 133.
HB1865 (Related) 2019-12-20 - Became Public Law No: 116-94. (TXT | PDF)
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
HB3947 (Related) 2019-08-28 - Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties.
Subjects
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Health
Licensing and registrations
Prescription drugs
Product development and innovation
Drug safety, medical device, and laboratory regulation
Health
Licensing and registrations
Prescription drugs
Product development and innovation